Aging population and lifestyle changes are leading to a steady increase in the prevalence of chronic medical conditions. The rapidly growing middle-class population and urbanization are driving the adoption of a sedentary lifestyle. The modernization of facilities reduces physical activities among people, while various personal, professional, and societal factors are adding to their stress levels. Arthritis; cardiovascular diseases, e.g., heart attacks and stroke; breast and colon cancer; diabetes; epilepsy and seizures; obesity; and oral health problems are among the leading chronic diseases reported among elderlies in developed countries. Chronic diseases affect public health, societies, and economies in various countries. Blood filters are widely used in various surgical procedures, such as cardiac surgery and other invasive procedures. Chronic diseases such as cancer, cardiovascular diseases, and renal disorders are the major causes of human death. These conditions are generally treated via surgical procedures, which are associated with a chance of excessive blood loss. Thus, these procedures are followed by the infusion of fresh blood to patients or reinfusion of their own blood. Blood filters are used during the blood infusion or reinfusion processes. Therefore, the Asia Pacific blood filter market is growing with the rapid increase in the burden of chronic diseases.
Currently, there is no proven specific therapy against COVID-19, and multiple novel and repurposed drugs are being used on an experimental basis. The lack of effective therapeutic options has been a major hurdle in pandemic mitigation measures. Studies show that blood filters result in minimizing the effect of cytokine storm created by COVID-19, which causes major organ destruction and may eventually lead to death in serious conditions. Thus, various companies have been initiating their supply process for the availability of blood filters to meet the dire need for the same in APAC. There are a few contender medicines including an antimalarial drug hydroxychloroquine, an antiviral Remdesivir and Ivermectin, and a drug used against worms and other parasites, but the results are not hugely encouraging and at times conflicting. Thus, plasma therapy gained traction as a cure for COVID-19 patients in India in 2020. Further, medical equipment used to conduct apheresis procedure were installed at many hospitals and blood collection centers; for example, GMCH, Thrissur, installed this machine for the first time in Kerala to administer plasma to a 51-year-old man.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 89,271.35 thousand |
| Market Size by 2028 | US$ 1,20,946.24 thousand |
| CAGR (2021 - 2028) | 4.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Blood Filter Market is valued at US$ 89,271.35 thousand in 2021, it is projected to reach US$ 1,20,946.24 thousand by 2028.
As per our report Asia Pacific Blood Filter Market, the market size is valued at US$ 89,271.35 thousand in 2021, projecting it to reach US$ 1,20,946.24 thousand by 2028. This translates to a CAGR of approximately 4.4% during the forecast period.
The Asia Pacific Blood Filter Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Blood Filter Market report:
The Asia Pacific Blood Filter Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Blood Filter Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Blood Filter Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Blood Filter Market
